Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,741.50
Bid: 1,741.00
Ask: 1,742.00
Change: -5.00 (-0.29%)
Spread: 1.00 (0.057%)
Open: 1,748.50
High: 1,752.50
Low: 1,737.50
Prev. Close: 1,746.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MARKET EARLY CALL: Stocks called higher; pound below USD1.20

Thu, 02nd Mar 2023 06:56

(Alliance News) - Stocks in London are set to open higher on Thursday, ahead of a eurozone inflation reading.

IG says futures indicate the FTSE 100 index of large-caps to open up 15.5 points, 0.2%, at 7,930.43 on Thursday. The index closed up 38.65 points, or 0.5% at 7,914.93 on Wednesday.

"European markets got off to a broadly negative start to the month yesterday, except for the FTSE 100, which managed to finish the session higher, due to a decent performance from the basic resource sector on optimism over the China reopening story," explained CMC Markets' Michael Hewson.

The pound softened further against the dollar, having dropped below USD1.20 as sterling's recent rally lost steam following cautious words from Bank of England Governor Andrew Bailey.

In a speech on Wednesday, Bailey said "nothing is decided" as far as interest rates go, and markets shouldn't assume more interest rate hikes are ahead.

Sterling was quoted at USD1.1987 early Thursday, slightly lower than USD1.1994 at the London equities close on Wednesday.

The day could be consequential for the euro, with a eurozone inflation reading due in at 1000 GMT.

Recent data from France, Spain and Germany have shown an upward trend to inflation, prompting fears of further hawkishness from the European Central Bank.

The euro traded at USD1.0640, down from USD1.0663. Against the yen, the dollar was quoted at JPY136.64, up versus JPY136.15.

In the US on Wednesday, Wall Street ended mixed, with the Dow Jones Industrial Average ending marginally higher, the S&P 500 up 0.5% and the Nasdaq Composite up 0.7%.

Late Wednesday, GSK said a US Food & Drug Administration committee voted unanimously to support the effectiveness of its respiratory syncytial virus vaccine, with the majority also supporting its safety.

It now expects a decision on US approval by May 3. GSK said the vaccine could potentially be the first approved for older adults.

In Tokyo on Thursday, the Nikkei 225 index closed down 0.1%. The Shanghai Composite was down 0.1%, while the Hang Seng index in Hong Kong was down 0.9%. The S&P/ASX 200 in Sydney closed up 0.1%.

Gold was quoted at USD1,833.06 an ounce early Thursday in London, lower than USD1,838.50 on Wednesday. Brent oil was trading at USD84.30 a barrel, higher than USD83.78.

In Thursday's UK corporate calendar, there are full-year results from London Stock Exchange Group, ITV, Haleon and National Express.

In the economic calendar, the EU will publish unemployment and inflation data at 1000 GMT. The US will publish its weekly unemployment claims report at 1330 GMT.

By Elizabeth Winter, Alliance News senior markets reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2023 Alliance News Ltd. All Rights Reserved.

More News
18 Dec 2023 07:55

LONDON BRIEFING: Games Workshop seals Amazon deal for Warhammer 40,000

(Alliance News) - Stocks in London were set to retreat slightly on Monday, in line with equity markets in Asia, at the start of the last week before the Christmas holidays.

Read more
18 Dec 2023 07:18

GSK sees success in Jemperli endometrial cancer trial

(Sharecast News) - GSK released positive headline results from the planned analysis of its trial of Jemperli in endometrial cancer on Monday.

Read more
17 Dec 2023 15:16

PRESS: GSK looks for deals in China as rebuilds relationship

(Alliance News) - The Financial Times on Sunday reported that GSK PLC is looking for some new deals in China.

Read more
15 Dec 2023 17:08

European shares end fifth week higher on rate-cut optimism

Barclays sees first ECB rate cut in April

*

Read more
15 Dec 2023 16:51

LONDON MARKET CLOSE: FTSE 100 underperforms as post-Fed rally cools

(Alliance News) - London's FTSE 100 ended lower on Friday, with profit-taking and some hawkish words from a US policymaker keeping equities in check at the end of a largely positive week for stocks.

Read more
15 Dec 2023 16:29

PRESS: GSK, Astra and AbbVie in US scrutiny over patents - Bloomberg

(Alliance News) - A US senator has accused AstraZeneca PLC, GSK PLC, AbbVie Inc and other drugmakers of "abusing" the patent system to send prices higher, Bloomberg reported on Thursday.

Read more
12 Dec 2023 10:08

AstraZeneca buys respiratory vaccine developer Icosavax in $1.1 bln deal

Dec 12 (Reuters) - AstraZeneca said on Tuesday it had agreed to buy respiratory syncytial virus (RSV) vaccine developer Icosavax in a deal valued at up to $1.1 billion.

Read more
12 Dec 2023 08:22

TOP NEWS: Japan accepts GSK's filing for respiratory disease vaccine

(Alliance News) - GSK PLC on Tuesday said Japan's Ministry of Health, Labour & Welfare has accepted its regulatory application for the extension of its respiratory syncytial virus vaccine, Arexvy, for adults aged 50-59.

Read more
12 Dec 2023 07:39

LONDON BRIEFING: UK unemployment unchanged at 4.2%; eyes on US CPI

(Alliance News) - Stocks in London are called to open higher, as investors digest the latest UK unemployment data, before turning their heads to US inflation.

Read more
12 Dec 2023 07:24

GSK seeks to extend RSV vaccine approval in Japan

(Sharecast News) - GSK announced on Tuesday that Japan's Ministry of Health, Labour and Welfare (MHLW) has accepted its regulatory application for the extension of the indication of its RSV vaccine to include adults aged 50- to 59 at an increased risk of contracting the disease.

Read more
11 Dec 2023 08:28

GSK drug gets EU marketing backing for form of endometrial cancer

(Alliance News) - GSK PLC on Monday said it won EU backing for its Jemperli drug in tandem with chemotherapy to treat a form of endometrial cancer.

Read more
11 Dec 2023 07:41

LONDON BRIEFING: GSK drug gets EU endorsement; Begbies backs outlook

(Alliance News) - London's FTSE 100 is called to open a touch lower on Monday, kicking off the week with some slight trepidation after Friday's hotter-than-expected US jobs report which offered the dollar some respite.

Read more
11 Dec 2023 07:23

GSK endometrial cancer treatment gets Europe authorisation

(Sharecast News) - GSK announced on Monday that the European Commission has granted marketing authorisation for 'Jemperli', or dostarlimab, in combination with chemotherapy for certain endometrial cancers.

Read more
7 Dec 2023 12:54

THG backer Kelso pushes for demerger to trim "inherent" valuation gap

(Alliance News) - THG PLC investor Kelso Group Holdings PLC on Thursday reiterated its call for a demerger, which the shareholder believes will help close the "disparity" between the e-commerce firm's share price and its true value.

Read more
5 Dec 2023 10:02

LONDON BROKER RATINGS: Goldman lifts Landsec and British Land

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.